Sea level budget over 2005–2013: missing contributions and data errors

by H. B. Dieng, A. Cazenave, K. von Schuckmann, M. Ablain, B. Meyssignac
Published 2015-10-01

Design and optimization of silicon nanostructures

by B. Dieng, M. Beye, M. Toure, D. Diouf, D. Kobor, A. S. Maiga
Published 2019-02-01

Readmission prediction via deep contextual embedding of clinical concepts.

by Cao Xiao, Tengfei Ma, Adji B Dieng, David M Blei, Fei Wang
Published 2018-01-01

Prevalence of bovine brucellosis and related risk behavior in the suburban area of Dakar, Senegal

by D. Tialla, P. Koné, M. C. Kadja, A. Kamga-Waladjo, C. B. Dieng, N. Ndoye, K.G. G. Kouame, S. Bakou, A. J. Akakpo
Published 2015-01-01

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

by Tandakha N. Dieye, Birahim P. NDiaye, Alle B. Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A. Diaw, Coumba Toure-Kane, Papa S. Sow, Souleymane Mboup, Helen McShane
Published 2013-01-01

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

by Tandakha N Dieye, Birahim P Ndiaye, Alle B Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A Diaw, Coumba Toure-Kane, Papa S Sow, Souleymane Mboup, Helen McShane
Published 2013-01-01

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.

by Tandakha N. Dieye, Birahim P. NDiaye, Alle B. Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A. Diaw, Coumba Toure-Kane, Papa S. Sow, Souleymane Mboup, Helen McShane
Published 2013-01-01